242 related articles for article (PubMed ID: 3002599)
1. Serum neuron-specific enolase in children with neuroblastoma. Relationship to stage and disease course.
Zeltzer PM; Marangos PJ; Evans AE; Schneider SL
Cancer; 1986 Mar; 57(6):1230-4. PubMed ID: 3002599
[TBL] [Abstract][Full Text] [Related]
2. Serum neuron-specific enolase in children's cancer.
Cooper EH; Pritchard J; Bailey CC; Ninane J
Br J Cancer; 1987 Jul; 56(1):65-7. PubMed ID: 3476145
[TBL] [Abstract][Full Text] [Related]
3. Raised neuron-specific enolase in serum of children with metastatic neuroblastoma. A report from the Children's Cancer Study Group.
Zeltzer PM; Marangos PJ; Parma AM; Sather H; Dalton A; Hammond D; Siegel SE; Seeger RC
Lancet; 1983 Aug; 2(8346):361-3. PubMed ID: 6135871
[TBL] [Abstract][Full Text] [Related]
4. Neuron-specific enolase evaluation in patients with neuroblastoma.
Massaron S; Seregni E; Luksch R; Casanova M; Botti C; Ferrari L; Martinetti A; Molteni SN; Bellani FF; Bombardieri E
Tumour Biol; 1998; 19(4):261-8. PubMed ID: 9679736
[TBL] [Abstract][Full Text] [Related]
5. Age dependence and prognostic impact of neuron specific enolase (NSE) in children with neuroblastoma.
Berthold F; Engelhardt-Fahrner U; Schneider A; Schumacher R; Zieschang J
In Vivo; 1991; 5(3):245-7. PubMed ID: 1893081
[TBL] [Abstract][Full Text] [Related]
6. Potential utility of serum neuron-specific enolase levels in small cell carcinoma of the lung.
Johnson DH; Marangos PJ; Forbes JT; Hainsworth JD; Van Welch R; Hande KR; Greco FA
Cancer Res; 1984 Nov; 44(11):5409-14. PubMed ID: 6091878
[TBL] [Abstract][Full Text] [Related]
7. Serial determination of serum neuron-specific enolase in patients with neuroblastoma and other pediatric tumors.
Tsuchida Y; Honna T; Iwanaka T; Saeki M; Taguchi N; Kaneko T; Koide R; Tsunematsu Y; Shimizu K; Makino S
J Pediatr Surg; 1987 May; 22(5):419-24. PubMed ID: 3585664
[TBL] [Abstract][Full Text] [Related]
8. Are levels of pro-gastrin-releasing peptide or neuron-specific enolase at relapse prognostic factors after relapse in patients with small-cell lung cancer?
Hirose T; Okuda K; Yamaoka T; Ishida K; Kusumoto S; Sugiyama T; Shirai T; Ohnshi T; Ohmori T; Adachi M
Lung Cancer; 2011 Feb; 71(2):224-8. PubMed ID: 20537424
[TBL] [Abstract][Full Text] [Related]
9. Serum neuron-specific enolase as a marker useful for monitoring the effectiveness of therapy in patients with neuroblastoma--as compared with urinary catecholamine metabolites.
Hashimoto K; Gotoh Y; Tada K
Tohoku J Exp Med; 1986 May; 149(1):25-30. PubMed ID: 3738914
[TBL] [Abstract][Full Text] [Related]
10. The diagnostic and prognostic value of pretreatment serum creatine kinase BB levels in patients with neuroblastoma.
Ishiguro Y; Kato K; Akatsuka H; Ito T
Cancer; 1990 May; 65(9):2014-9. PubMed ID: 2372768
[TBL] [Abstract][Full Text] [Related]
11. [The use of neuron specific enolase in the prognosis and followup of neuroblastoma in children. Results of a retrospective series of 21 patients].
Abdennebi M; Boussen H; Harzallah L; Daldoul O; Ghanem A; Gamoudi A; Ben Slimene F; Rahal K; el May A; Ben Ayed F; Guemira F
Tunis Med; 2000 Feb; 78(2):106-8. PubMed ID: 10894045
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of neural isozymes by human medulloblastomas and gliomas and neuroectodermal cell lines.
Zeltzer PM; Schneider SL; Marangos PJ; Zweig MH
J Natl Cancer Inst; 1986 Sep; 77(3):625-31. PubMed ID: 3462406
[TBL] [Abstract][Full Text] [Related]
13. Value of serum neuron-specific enolase in nonsmall cell lung cancer.
Diez M; Torres A; Ortega L; Maestro M; Hernando F; Gomez A; Picardo A; Granell J; Balibrea JL
Oncology; 1993; 50(2):127-31. PubMed ID: 8383830
[TBL] [Abstract][Full Text] [Related]
14. [The value of neuron specific enolase (NSE) in patients with brain tumors].
Taomoto K; Kokunai T; Okuda T; Tamaki N; Matsumoto S; Hashimoto N
No To Shinkei; 1987 Feb; 39(2):169-73. PubMed ID: 3828153
[TBL] [Abstract][Full Text] [Related]
15. Chromogranin A and neuron-specific enolase in neuroblastoma: Correlation to stage and prognostic factors.
Georgantzi K; Sköldenberg EG; Stridsberg M; Kogner P; Jakobson Å; Janson ET; Christofferson RHB
Pediatr Hematol Oncol; 2018 Mar; 35(2):156-165. PubMed ID: 29737901
[TBL] [Abstract][Full Text] [Related]
16. Serum neuron-specific/nonneuronal enolase ratio in the diagnosis of neuroblastomas.
Viallard JL; Tiget F; Hartmann O; Lemerle J; Demeocq F; Malpuech G; Dastugue B
Cancer; 1988 Dec; 62(12):2546-53. PubMed ID: 3191453
[TBL] [Abstract][Full Text] [Related]
17. Serum neuron-specific enolase. A marker for disease extent and response to therapy for small-cell lung cancer.
Akoun GM; Scarna HM; Milleron BJ; Bénichou MP; Herman DP
Chest; 1985 Jan; 87(1):39-43. PubMed ID: 2981171
[TBL] [Abstract][Full Text] [Related]
18. Serum neuron-specific enolase: a marker for disease extent and response to therapy of small-cell lung cancer.
Carney DN; Marangos PJ; Ihde DC; Bunn PA; Cohen MH; Minna JD; Gazdar AF
Lancet; 1982 Mar; 1(8272):583-5. PubMed ID: 6121182
[TBL] [Abstract][Full Text] [Related]
19. Urine neuron-specific enolase and its clinical implication in patients with neuroblastoma.
Gotoh Y; Hashimoto K; Tada K
Tohoku J Exp Med; 1986 May; 149(1):67-72. PubMed ID: 3738918
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the relationship between MYCN gene and serum NSE and urinary VMA levels and neuroblastoma pathological features and prognosis.
Zhang H; He X; Miao Q; Li L; Song J; Jiang X
Cell Mol Biol (Noisy-le-grand); 2024 Apr; 70(4):134-139. PubMed ID: 38678619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
